Literature DB >> 17320412

Impact of vCJD on blood supply.

Rainer Seitz1, Friedger von Auer, Johannes Blümel, Reinhard Burger, Anne Buschmann, Klaus Dietz, Margarethe Heiden, Walter E Hitzler, Horst Klamm, Thomas Kreil, Hans Kretzschmar, Micha Nübling, Ruth Offergeld, Georg Pauli, Volkmar Schottstedt, Peter Volkers, Inga Zerr.   

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is an at present inevitably lethal neurodegenerative disease which can only be diagnosed definitely post mortem. The majority of the approximately 200 victims to date have resided in the UK where most contaminated beef materials entered the food chain. Three cases in the UK demonstrated that vCJD can be transmitted by blood transfusion. Since BSE and vCJD have spread to several countries outside the UK, it appears advisable that specific risk assessments be carried out in different countries and geographic areas. This review explains the approach adopted by Germany in assessing the risk and considering precautionary measures. A fundamental premise is that the feeding chain of cattle and the food chain have been successfully and permanently cleared from contaminated material. This raises the question of whether transmissions via blood transfusions could have the potential to perpetuate vCJD in mankind. A model calculation based on actual population data showed, however, that this would not be the case. Moreover, an exclusion of transfusion recipients from blood donation would add very little to the safety of blood transfusions, but would have a considerable impact on blood supply. Therefore, an exclusion of transfusion recipients was not recommended in Germany.

Entities:  

Mesh:

Year:  2007        PMID: 17320412     DOI: 10.1016/j.biologicals.2007.01.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  7 in total

1.  Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Quality and Safety in Blood Supply in 2010.

Authors:  Rainer Seitz; Margarethe Heiden
Journal:  Transfus Med Hemother       Date:  2010-05-20       Impact factor: 3.747

3.  A molecular switch controls interspecies prion disease transmission in mice.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Giuseppe Manco; Natalia Fernández-Borges; Petra Schwarz; Joaquín Castilla; Kurt Wüthrich; Adriano Aguzzi
Journal:  J Clin Invest       Date:  2010-06-14       Impact factor: 14.808

4.  Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain.

Authors:  Qingzhong Kong; Mengjie Zheng; Cristina Casalone; Liuting Qing; Shenghai Huang; Bikram Chakraborty; Ping Wang; Fusong Chen; Ignazio Cali; Cristiano Corona; Francesca Martucci; Barbara Iulini; Pierluigi Acutis; Lan Wang; Jingjing Liang; Meiling Wang; Xinyi Li; Salvatore Monaco; Gianluigi Zanusso; Wen-Quan Zou; Maria Caramelli; Pierluigi Gambetti
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

5.  Donating blood for research: a potential method for enhancing customer satisfaction of permanently deferred blood donors.

Authors:  Daniel Waller; Amanda Thijsen; Allira Garradd; Jane Hayman; Geoff Smith
Journal:  Blood Transfus       Date:  2015-11-30       Impact factor: 3.443

6.  Absence of classical and atypical (H- and L-) BSE infectivity in the blood of bovines in the clinical end stage of disease as confirmed by intraspecies blood transfusion.

Authors:  Anne Balkema-Buschmann; Ute Ziegler; Grit Priemer; Kerstin Tauscher; Frauke Köster; Ivett Ackermann; Olanrewaju I Fatola; Daniel Balkema; Jan Schinköthe; Bärbel Hammerschmidt; Christine Fast; Reiner Ulrich; Martin H Groschup
Journal:  J Gen Virol       Date:  2021-01       Impact factor: 3.891

7.  The variant Creutzfeldt-Jakob Disease: Risk, uncertainty or safety in the use of blood and blood derivatives?

Authors:  Antonio Liras
Journal:  Int Arch Med       Date:  2008-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.